낭성 섬유증이 없었던 환자에서 폐이식 후 발생한 Burkholderia cepacia 폐렴
A Case of Burkholderia cepacia Pneumonia after Lung Transplantation in a Recipient without Cystic Fibrosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Burkholderia cepacia is a highly virulent pathogen known to cause opportunistic infections in immunocompromised patients. It accelerates lung disease and causes necrotizing pneumonia with associated severe sepsis, known as cepacia syndrome. In particular, lung transplant recipients infected with Burkholderia cepacia show higher mortality after lung transplantation than those who are not infected with this organism. Due to broad-spectrum antibiotic resistance, a combination therapy should be used according to the results of the susceptibility test. This bacterial infection is rare in Korea, and no case was reported in lung transplant recipients. However, we report a case of pneumonia caused by Burkholderia cepacia after lung transplantation. As Burkholderia cepacia was grown from a sputum culture, the patient was treated initially with a combination of meropenem and trimethoprim/sulfamethoxazole and then ceftazidime and trimethoprim/sulfamethoxazole as a result of leukopenia. After antibiotics treatment for 20 days, sputum cultures became negative for Burkholderia cepacia and the patient successfully recovered.
Abstract
Burkholderia cepacia is a highly virulent pathogen known to cause opportunistic infections in immunocompromised patients. It accelerates lung disease and causes necrotizing pneumonia with associated severe sepsis, known as cepacia syndrome. In particular, lung transplant recipients infected with Burkholderia cepacia show higher mortality after lung transplantation than those who are not infected with this organism. Due to broad-spectrum antibiotic resistance, a combination therapy should be used according to the results of the susceptibility test. This bacterial infection is rare in Korea, and no case was reported in lung transplant recipients. However, we report a case of pneumonia caused by Burkholderia cepacia after lung transplantation. As Burkholderia cepacia was grown from a sputum culture, the patient was treated initially with a combination of meropenem and trimethoprim/sulfamethoxazole and then ceftazidime and trimethoprim/sulfamethoxazole as a result of leukopenia. After antibiotics treatment for 20 days, sputum cultures became negative for Burkholderia cepacia and the patient successfully recovered.
참고문헌 (20)
- Speert DP, "Advances in Burkholderia cepacia complex", Paediatr Respir Rev, 3, pp.230~235 (2002)
- Mangram A, "Nosocomial Burkholderia cepacia outbreaks and pseudo-outbreaks", Infect Control Hosp Epidemiol, 17, pp.718~720 (1996)
- 이정화, "A case of lung abscess caused by Burkholderia cepacia in healthy child", Korean Journal of Pediatrics, 50(1), pp.89~94 (2007), 대한소아과학회
- 강형민, "복막투석 환자에서 발생한 Burkholderia cepacia 복막염 1예", 대한내과학회지, 71(2), pp.219~223 (2006), 대한내과학회
- 장미옥, "Meropenem 단독요법에 반응하지 않았으나, ceftazidime과 trimethoprim- sulfamethoxazole 병합투여로 치료한 Burkholderia 균 혈증 및 감염성 척추염 1례", Infection and Chemotherapy, 43(6), pp.490~493 (2011), 대한감염학회
- 양병혁, "Pyogenic Spondylitis in a Healthy Adult Caused by Burkholderia cepacia", Infection and Chemotherapy, 40(4), pp.233~236 (2008), 대한감염학회
- Huang CH, "Characteristics of patients with Burkholderia cepacia bacteremia", J Microbiol Immunol Infect, 34, pp.215~219 (2001)
- Levine SM, "Transplant", Immunology Network of the American College of Chest Physicians: A survey of clinical practice of lung transplantation in North America, 2004, pp.125, 1224~1238
- Nash EF, "Survival of Burkholderia cepacia sepsis following lung transplantation in recipients with cystic fibrosis", Transpl Infect Dis, 12, pp.551~554 (2010)
- Snell GI, "Pseudomonas cepacia in lung transplant recipients with cystic fibrosis", Chest, 103, pp.466~471 (1993)
- Chaparro C, "Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation", Am J Respir Crit Care Med, 163, pp.43~48 (2001)
- De Soyza A, "Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis", Lancet, 358, pp.1780~1781 (2001)
- Lu DC, "In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood", Diagn Microbiol Infect Dis, 28, pp.187~191 (1997)
- Ki HK, "A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors", BMC Infect Dis, 11, pp.114~ (2011)
- Lipuma JJ, "Burkholderia cepacia complex as human pathogens", J Nematol, 35, pp.212~217 (2003)
- Isles A, "Pseudomonas cepacia infection in cystic fibrosis: an emerging problem", J Pediatr, 104, pp.206~210 (1984)
- Winkelstein JA, "Chronic granulomatous disease. Report on a national registry of 368 patients", Medicine (Baltimore), 79, pp.155~169 (2000)
- Govan JR, "Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis", Lancet, 342, pp.15~19 (1993)
- Shaw D, "Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide", FEMS Immunol Med Microbiol, 11, pp.99~106 (1995)
- Jeong JY, "Vancomycin-resistant enterococcus and methicillin-resistant staphylococcus aureus colonization in liver transplant recipients: a matched control study", Korean J Crit Care Med, 21, pp.95~100 (2006)